Delivery Order SPE2DE24D0013-SPE2D626F87E7
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $9,216.80 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 17, 2025. This delivery order, designated XPRSMVP-10 (Contract Number 4570254413), represents a continuation of the federal government's reliance on Cepheid's diagnostic capabilities. The contract utilizes no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. The contract, designated as XPRSMVP-10 and issued under a firm fixed-price arrangement with no set-aside designation, supports the agency's procurement of molecular diagnostic solutions. As a leading federal supplier of advanced diagnostic systems and reagents, Cepheid...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,800 on January 6, 2026, under a Defense Logistics Agency Medical Supply Chain contract. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic systems and reagents. The award carries no set-aside designation, reflecting Cepheid's competitive positioning...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a delivery order valued at $2,765.04 by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with ultimate completion by January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, requires no set-aside designation and is being performed at Cepheid's Sunnyvale headquarters. The contract falls under the company's established relationship with the Defense...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,597.30 under a Defense Logistics Agency Medical Supply Chain contract (4570223169). This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of December 16, 2025, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $2,304.20 by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning in the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $38,461.80 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain on December 22, 2025. The delivery order, designated XPRSMVP-10, is scheduled for completion by January 7, 2026, and carries no set-aside designation. This award represents a continuation of Cepheid's established role as a primary federal supplier of...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $2,765.04 on December 16, 2025, under the Defense Logistics Agency Medical Supply Chain contract vehicle. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by December 23, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no small business set-aside designation, reflecting Cepheid's established competitive...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F87E7Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,448.40 by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents a continuation of Cepheid's role as a primary federal supplier of diagnostic solutions. The contract falls under the company's broader relationship with federal healthcare agencies, where Cepheid supplies GeneXpert diagnostic platforms, molecular testing reagents, test kits, and maintenance services for detecting infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other clinical conditions. Cepheid's extensive federal contracting portfolio demonstrates its established position within the defense and civilian healthcare supply chain. The company holds significant indefinite delivery contracts with the Department of Veterans Affairs, including a $32.8 million agreement with VISN 6 extending through September 2030 and a $6.7 million contract with VISN 17 through December 2029, which generate numerous delivery orders across VA medical centers nationwide. These vehicles, combined with contracts from the Defense Health Agency, Indian Health Service, and U.S. Coast Guard, position Cepheid as a critical supplier of molecular diagnostic capabilities to the federal government's distributed healthcare network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 1/6/26 |